These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22876963)

  • 1. Metavanadate at the active site of the phosphatase VHZ.
    Kuznetsov VI; Alexandrova AN; Hengge AC
    J Am Chem Soc; 2012 Sep; 134(35):14298-301. PubMed ID: 22876963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of the phosphatase VHZ revealed by a high-resolution structure with vanadate and substrate screening.
    Kuznetsov VI; Hengge AC; Johnson SJ
    Biochemistry; 2012 Dec; 51(49):9869-79. PubMed ID: 23145819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the PTPase-vanadate complex a true transition state analogue?
    Deng H; Callender R; Huang Z; Zhang ZY
    Biochemistry; 2002 May; 41(18):5865-72. PubMed ID: 11980490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate.
    Zhang M; Zhou M; Van Etten RL; Stauffacher CV
    Biochemistry; 1997 Jan; 36(1):15-23. PubMed ID: 8993313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical, biochemical, and biological behaviors of vanadate and its oligomers.
    Yang XG; Wang K
    Prog Mol Subcell Biol; 2013; 54():1-18. PubMed ID: 24420708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New functional aspects of the atypical protein tyrosine phosphatase VHZ.
    Kuznetsov VI; Hengge AC
    Biochemistry; 2013 Nov; 52(45):8012-25. PubMed ID: 24073992
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Machado LESF; Page R; Peti W
    Biomol NMR Assign; 2018 Apr; 12(1):5-9. PubMed ID: 28856606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadate inhibition of fungal PhyA and bacterial AppA2 histidine acid phosphatases.
    Ullah AH; Sethumadhavan K; Mullaney EJ
    J Agric Food Chem; 2011 Mar; 59(5):1739-43. PubMed ID: 21294512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sites.
    Moise G; Gallup NM; Alexandrova AN; Hengge AC; Johnson SJ
    Biochemistry; 2015 Oct; 54(42):6490-500. PubMed ID: 26445170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate.
    Huyer G; Liu S; Kelly J; Moffat J; Payette P; Kennedy B; Tsaprailis G; Gresser MJ; Ramachandran C
    J Biol Chem; 1997 Jan; 272(2):843-51. PubMed ID: 8995372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A characterization of pervanadate, an inducer of cellular tyrosine phosphorylation and inhibitor of gap junctional intercellular communication.
    Mikalsen SO; Kaalhus O
    Biochim Biophys Acta; 1996 Aug; 1290(3):308-18. PubMed ID: 8765135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vanadium-51 NMR study of the binding of vanadate and peroxovanadate to proteins.
    Rehder D; Casný M; Grosse R
    Magn Reson Chem; 2004 Sep; 42(9):745-9. PubMed ID: 15307055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
    Crans DC
    J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.
    Fantus IG; Deragon G; Lai R; Tang S
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):103-12. PubMed ID: 8927024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
    Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
    Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimal essential core of a cysteine-based protein-tyrosine phosphatase revealed by a novel 16-kDa VH1-like phosphatase, VHZ.
    Alonso A; Burkhalter S; Sasin J; Tautz L; Bogetz J; Huynh H; Bremer MC; Holsinger LJ; Godzik A; Mustelin T
    J Biol Chem; 2004 Aug; 279(34):35768-74. PubMed ID: 15201283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex.
    Bond CS; White MF; Hunter WN
    J Mol Biol; 2002 Mar; 316(5):1071-81. PubMed ID: 11884145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a human lysosomal sulfatase.
    Bond CS; Clements PR; Ashby SJ; Collyer CA; Harrop SJ; Hopwood JJ; Guss JM
    Structure; 1997 Feb; 5(2):277-89. PubMed ID: 9032078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism.
    Lindqvist Y; Schneider G; Vihko P
    Eur J Biochem; 1994 Apr; 221(1):139-42. PubMed ID: 8168503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.